Related Experiment Video
Updated: Jul 16, 2026
04:43
COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
Pertussis seroprevalence in different age groups in Greece
Ioanna D Pavlopoulou1, Vassiliki Syriopoulou, George L Daikos
1First Department of Paediatrics, Athens University, Athens, Greece. idpavlop@yahoo.gr
Scandinavian Journal of Infectious Diseases
|March 17, 2007
Summary
Antibody levels against pertussis toxin (PT) vary by age and immunization status. Findings suggest optimizing pertussis booster vaccination strategies for different age groups.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- Pertussis toxin (PT) is a key virulence factor in *Bordetella pertussis*.
- Understanding antibody titers against PT is crucial for assessing vaccine effectiveness and informing public health policy.
- Immune responses to pertussis vaccination can wane over time, necessitating booster doses.
Purpose of the Study:
- To investigate antibody titers against pertussis toxin (PT) across various age groups.
- To compare antibody levels in immunized individuals versus non-immunized controls.
- To identify age-specific patterns in anti-PT antibody levels to guide booster vaccination strategies.
Main Methods:
- Measurement of antibody titres against pertussis toxin (PT) in serum samples.
- Stratification of participants into different age groups.
- Comparison of antibody levels between immunized and non-immunized cohorts.
Main Results:
- In immunized individuals, highest anti-PT levels were found in the 0-2 year age group, with lower levels in teenagers and young adults.
- In non-immunized controls, anti-PT levels were low in infants, increased in adolescence/early adulthood, and declined after age 30.
- Antibody levels >30 U/ml were more frequent in young children (<2 years), those with complete vaccination history, and non-immunized individuals.
Conclusions:
- Age and immunization history significantly impact antibody titres against pertussis toxin.
- Current vaccination policies may need adjustment to ensure sustained protection across all age groups.
- Further research is warranted to optimize pertussis booster vaccination schedules based on age-specific antibody dynamics.
Related Concept Videos
01:28Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
01:08Prevalence and Incidence
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
01:28Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:28Diphtheria
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
01:51Vaccinations
Overview